EPHA5 and breast carcinoma: This research was funded by the Canadian Institutes of Health Research (CIHR) Foundation Award FDN-148373; the Canada Research Chair in Molecular Oncology (to WJM) (CRC, 950231033 X216779); the CURE Foundation Fellowship in Breast Cancer Research; a George G. Harris Fellowship (to IN); the US Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Breast Cancer Research Program (BRCP) (W81XWH-11-1-0046, to HWS); and the Breast Cancer Research Foundation (BCRF-083, to BSK and BCRF-084, to JAK and BSK).